The Data Disaster in the U.S.

In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavir ...  Show more

The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract th ...  Show more

We are over four months into the Covid-19 pandemic and the U.S. still doesn't have the testing capabilities, contact tracing, or political buy-in that many other countries have used to fight this virus. CNN’s Chief Medical Correspondent Dr. Sanjay Gupta talks with Dr. Zeke Emanue ...  Show more

Data is the lifeblood of public health, and has been since the beginning of the field. But essential data gathering for the COVID pandemic was hindered by a couple of of underlying weakness in the US public health apparatus. We have a fractured system where the power lies in U ...

The U.S. is setting devastating new records nine months into this pandemic. CNN Chief Medical Correspondent Dr. Sanjay Gupta answers listener questions amidst this time of growing uncertainty.  To learn more about how CNN protects listener privacy, visit cnn.com/privacy Learn mor ...  Show more

State and local pandemic responses are scattershot; a national effort is all but nonexistent. A creeping sense of fatalism makes for peril far beyond the country’s borders. Aggregate American jobs numbers are promising, but our correspondent digs deeper to find <a href="https://w ...  Show more